Market Value520,942,000
Total Holdings65
File Date2020-05-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
TMO / Thermo Fisher Scientific Inc.
US69354M1080 / PRA Health Sciences Inc
US0153511094 / Alexion Pharmaceuticals, Inc.
VCEL / Vericel Corporation
PPD / PPD Inc
US40425J1016 / HMS Holdings Corp.
CHNG / Change Healthcare Inc
AERI / Aerie Pharmaceuticals Inc
HRC / Hill-Rom Holdings Inc
NXTC / NextCure, Inc.
VCRA / Vocera Communication Inc
TRHC / Tabula Rasa HealthCare Inc
COLL / Collegium Pharmaceutical, Inc.
QURE / uniQure N.V.
CSII / Cardiovascular Systems Inc.
/ Immunomedics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
GBT / Global Blood Therapeutics Inc.
STML / Stemline Therapeutics, Inc.
APRE / Aprea Therapeutics, Inc.
PHAS / PhaseBio Pharmaceuticals Inc
EVLO / Evelo Biosciences, Inc.
FGEN / FibroGen, Inc.
SAGE / Sage Therapeutics, Inc.
MTEM / Molecular Templates, Inc.
TDOC / Teladoc Health, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
SGEN / Seagen Inc
FIXX / Homology Medicines, Inc.
IRTC / iRhythm Technologies, Inc.
0PP / Portola Pharmaceuticals Inc
TFX / Teleflex Incorporated
ASMB / Assembly Biosciences, Inc.
TPTX / Turning Point Therapeutics Inc
RETA / Reata Pharmaceuticals Inc - Class A
RCM / R1 RCM Inc.
MRTX / Mirati Therapeutics, Inc.
TNDM / Tandem Diabetes Care, Inc.
GH / Guardant Health, Inc.
MGTX / MeiraGTx Holdings plc
INSP / Inspire Medical Systems, Inc.
BPMC / Blueprint Medicines Corporation
SILK / Silk Road Medical, Inc
PTCT / PTC Therapeutics, Inc.
ATRC / AtriCure, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
EXEL / Exelixis, Inc.
COGT / Cogent Biosciences, Inc.
MRNA / Moderna, Inc.
CRSP / CRISPR Therapeutics AG
FOLD / Amicus Therapeutics, Inc.
MRK / Merck & Co., Inc.
APLS / Apellis Pharmaceuticals, Inc.
BMRN / BioMarin Pharmaceutical Inc.
GILD / Gilead Sciences, Inc.
RCUS / Arcus Biosciences, Inc.
UNH / UnitedHealth Group Incorporated
REGN / Regeneron Pharmaceuticals, Inc.
CI / The Cigna Group
BSX / Boston Scientific Corporation
ILMN / Illumina, Inc.
EVH / Evolent Health, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
INCY / Incyte Corporation
LLY / Eli Lilly and Company
ABBV / AbbVie Inc.
AMGN / Amgen Inc.
ZBH / Zimmer Biomet Holdings, Inc.
MDT / Medtronic plc
ABT / Abbott Laboratories
BMY / Bristol-Myers Squibb Company
PFE / Pfizer Inc.
BIIB / Biogen Inc.
SRPT / Sarepta Therapeutics, Inc.